The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death

被引:436
作者
Meier-Kriesche, HU [1 ]
Arndorfer, JA [1 ]
Kaplan, B [1 ]
机构
[1] Univ Florida, Shands Hosp, Div Nephrol, Gainesville, FL 32610 USA
关键词
D O I
10.1097/00007890-200201150-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Renal transplant recipients with elevated body mass index (BMI) have been shown to have inferior patient survival as compared to patients with lower BMI. However, previous studies could not establish a link between increased BMI and decreased death censored graft survival. Obesity in nontransplant patients has been associated with hypertension, hyperlipidemia, type 11 diabetes, proteinuria and glomerulopathy. Given this evidence it is possible that renal transplant recipients with an elevated BMI may have worse long term graft survival. To investigate this hypothesis we retrospectively analyzed 51,927 primary, adult renal transplants registered in the USRDS. Methods. BMI at date of transplant was calculated for all patients using BMI=body weight (in kg) is approximately equal to stature (height, in meters) squared. BAH values were further categorized into 11 categories: below 18, from IS to 36 at 2 unit increments, and above 36 kg/m(2). Primary study end points were graft and patient survival. Secondary study end points were death censored graft survival, chronic allograft failure, delayed graft function, and acute rejection (AR). Cox proportional hazard and logistic regression models investigated the link between categorized BMI and the study end points correcting for potential confounding variables. Results. BMI showed a very strong association with outcomes after renal transplantation. The extremes of very high and very low BMI were associated with significantly worse patient and graft survival. The same was true for death censored graft survival and chronic allograft failure. Elevated BMI was also associated with an increased risk for delayed graft function while lower BMI was significantly protective. Acute rejection did not show any significant association with BMI. Conclusions. BMI has a very strong association with outcomes after renal transplantation independent of most of the known risk factors for patient and graft survival. The extremes of very high and very low BMI before renal transplantation are important risk factors for patient and graft survival. It is important to note that elevated BAH was significantly associated with worse graft survival independent of patient survival. Whether prospective weight adjustment before renal transplantation can favorably affect posttransplant risk needs to be assessed by further studies.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 15 条
[1]   Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis [J].
Bonnet, F ;
Deprele, C ;
Sassolas, A ;
Moulin, P ;
Alamartine, E ;
Berthezène, F ;
Berthoux, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :720-727
[2]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[3]   Hyperlipidemia as a risk factor of renal allograft function impairment [J].
Carvalho, MFC ;
Soares, V .
CLINICAL TRANSPLANTATION, 2001, 15 (01) :48-52
[4]  
Drafts HH, 1997, CLIN TRANSPLANT, V11, P493
[5]   Risk factor paradox in hemodialysis: Better nutrition as a partial explanation [J].
Fleischmann, EH ;
Bower, JD ;
Salahudeen, AK .
ASAIO JOURNAL, 2001, 47 (01) :74-81
[6]   Obesity and mortality in ESRD: Is it good to be fat? [J].
Hakim, RM ;
Lowrie, E .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1580-1581
[7]   Mechanisms of hypertension and kidney disease in obesity [J].
Hall, JE ;
Brands, MW ;
Henegar, JR .
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS, 1999, 892 :91-107
[8]  
Halme L, 1997, TRANSPLANT INT, V10, P284
[9]  
HOWARD R, 2001, AJT, V1, P399
[10]  
Johnson DW, 2000, PERITON DIALYSIS INT, V20, P715